VaxEquity

Cambridge, United States

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

$870K raised

Jun 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VaxEquity raised?

VaxEquity has raised $870K in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are VaxEquity's investors?

VaxEquity's investors include Innovate UK, Morningside Venture Partners.

Where is VaxEquity headquartered?

VaxEquity is headquartered in Cambridge, United States.

What does VaxEquity do?

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

What stage is VaxEquity at?

VaxEquity is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 5, 2023.

MLA

"VaxEquity — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/vaxequity. Accessed July 2, 2026.

APA

VCBacked. (2023). VaxEquity — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vaxequity

Wikipedia (cite web)

{{cite web |title=VaxEquity — Funding & Investors |url=https://www.vcbacked.co/company/vaxequity |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 5, 2023.